[1]袁仁智,肖卫琼,唐鹏,等.巴戟天-续断-益母草组药干预肾虚血瘀型多囊卵巢综合征网络药理学作用机制[J].西部中医药,2021,34(05):14-21.[doi:10.12174/j.issn.2096-9600.2021.05.05]
　YUAN Renzhi,XIAO Weiqiong,TANG Peng,et al.Network Pharmacological Mechanism of Bajitian-Xuduan-Yimucao Drug Combination in the Internvetion for PCOS of Kidney-deficiency Blood-stasis Pattern[J].Western Journal of Traditional Chinese Medicine,2021,34(05):14-21.[doi:10.12174/j.issn.2096-9600.2021.05.05]
点击复制

巴戟天-续断-益母草组药干预肾虚血瘀型多囊卵巢综合征网络药理学作用机制
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年05期
页码:
14-21
栏目:
出版日期:
2021-05-15

文章信息/Info

Title:
Network Pharmacological Mechanism of Bajitian-Xuduan-Yimucao Drug Combination in the Internvetion for PCOS of Kidney-deficiency Blood-stasis Pattern
作者:
袁仁智1,2,3, 肖卫琼1,3, 唐鹏1,2, 康开彪2, 潘文2
1.甘肃省中医院，甘肃 兰州 730050
2.甘肃省中医药研究院
3.邵阳学院
Author(s):
YUAN Renzhi1,2,3, XIAO Weiqiong1,3, TANG Peng1,2, KANG Kaibiao2, PAN Wen2
1.Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China
2.Gansu Provincial Academy of Chinese Medicine
3.Shaoyang University
关键词:
多囊卵巢综合征; 肾虚血瘀; 网络药理学; 巴戟天; 续断; 益母草
Keywords:
PCOS; kidney-deficiency blood-stasis pattern; network pharmacology
分类号:
R271
DOI:
10.12174/j.issn.2096-9600.2021.05.05
摘要:
目的运用网络药理学方法和技术研究“巴戟天-续断-益母草”组药治疗多囊卵巢综合征（polycystic ovarian syndrome，PCOS）的主要活性成分、靶点、通路等药理学作用机制。 方法通过数据挖掘获得PCOS肾虚血瘀型核心组药巴戟天-续断-益母草；检索中药系统药理学数据库分析平台（traditional Chinese medicine systems pharmacology database and analysis platform，TCMSP），筛选出巴戟天-续断-益母草的活性成分和潜在靶点；查询NCBI数据库获得PCOS疾病靶点，找到药物和疾病的共靶点；通过DAVID数据库对共靶点进行基因功能GO富集分析和KEGG富集分析；采用Cytoscape软件构建成分-靶标、靶标-通路网络。 结果从“巴戟天-续断-益母草”组药中筛选得到26个候选活性分子，作用于719个靶点，找到PCOS疾病靶点228个，两者共有靶点22个，主要涉及炎性反应、细胞因子、雌激素、胰岛素抵抗等生物学过程中的多条信号通路。 结论本研究初步揭示“巴戟天-续断-益母草”组药的主要活性成分、靶点及协同作用机制，为进一步深入探讨其药理学作用提供了参考。
Abstract:
ObjectiveTo study main active ingredients, target spot, pathway and others of "Bajitian-Xuduan-Yimucao" drug combinations in the treatment for polycystic ovarian syndrome (PCOS) using network pharmcological method and technology. MethodsCore drug combinations "Bajitian-Xuduan-Yimucao" for PCOS of kidney-deficiency blood-stasis pattern were obtained by data mining; active ingredients and potiential target spot of "Bajitian-Xuduan-Yimucao"were screened by searching traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP); PCOS disease target spots, common target spots of drugs and diseases were obtained by searching NCBI database; Gene function Go concentration analysis and KEGG concentration analysis of the common target spots were performed using DAVID database; ingredient-target spot, target spot-pathway network were constructed by adopting Cytoscape software. ResultsAll 26 candidate bioactive molecules were selected from "Bajitian-Xuduan-Yimucao" drug combinations, and they acted on 719 target spots, 228 PCOS disease target spots were found, 22 common target spots, and many signal channels about inflammtory reaction, cytokines, estrogen, insuslin resistance and others in the biological process were involved mainly. ConclusionThe study preliminarily reveals main active ingredients, target spots and synergistic mechanism of the drug combinations, and it could provide the reference for further exploration into its pharmacology.

相似文献/References:

[1]潘文,王贵霞,王晓萍.多囊卵巢综合征伴胰岛素抵抗的发病机制研究及中药干预作用[J].西部中医药,2012,25(12):121.
　PAN Wen,WANG Gui-xia,WANG Xiao-ping.Study on Pathogenesis of Polycystic Ovary Syndrome Complicated with Insulin Resistance and Intervention with Traditional Chinese Medicine[J].Western Journal of Traditional Chinese Medicine,2012,25(05):121.
[2]王针织,周丽虹,俞超芹△,等.补肾活血祛痰方治疗肥胖型与非肥胖型多囊卵巢综合征的疗效研究*[J].西部中医药,2014,27(04):1.
　WANG Zhenzhi,ZHOU Lihong,YU Chaoqin,et al.Study on Clinical Effects of Kidney-invigorating Blood-activating Phlegm-eliminating Prescription in Treating Polycystic Ovary Syndrome of Obesity Type and Non-obesity Type[J].Western Journal of Traditional Chinese Medicine,2014,27(05):1.
[3]苏庆华,张建伟△.多囊卵巢综合征中医证型与内分泌代谢指标相关性研究[J].西部中医药,2014,27(04):143.
　SU Qinghua,ZHANG Jianwei.Research on the Relativity between the Indexes of Metabolic Endocrinology and TCM Patterns of PCOS[J].Western Journal of Traditional Chinese Medicine,2014,27(05):143.
[4]康开彪,牛崇信,指导：潘文.潘文教授对多囊卵巢综合征中医病因的认识[J].西部中医药,2014,27(08):22.
[5]谢志燕,常惠△.从“肾虚血瘀”论治复发性流产血栓前状态[J].西部中医药,2015,28(02):99.
[6]汪雪晴,曾敬.补肾调经方联合达英-35治疗多囊卵巢综合征疗效观察[J].西部中医药,2012,25(11):78.
　WANG Xue-qing,ZENG Jing.Clinical Observation on BuShen TiaoJingFang Combined with Ethinylestradiol and Cyproterone Acetate Tablets for Polycystic Ovary Syndrome[J].Western Journal of Traditional Chinese Medicine,2012,25(05):78.
[7]梁荣伟,刘新雄,李学余,等.穴位针刺加封闭联合辅助生殖技术对 PCOS 不孕患者激素水平的影响*[J].西部中医药,2013,26(02):98.
　LIANG Rongwei,LIU Xinxiong,LI Xueyu,et al.The Effects of Acupoint Block, Needling and Assisted Reproductive Technique on the Level of Hormone in Infertile Patients with PCOS[J].Western Journal of Traditional Chinese Medicine,2013,26(05):98.
[8]张翌蕾,潘文△,汪永娟,等.补肾化瘀方对PCOS大鼠血清激素水平的影响[J].西部中医药,2016,29(02):5.
　ZHANG Yilei,PAN Wen,WANG Yongjuan,et al.The Influence of BuShen HuaYu Prescription on the Levels of Hormone of PCOS Rats[J].Western Journal of Traditional Chinese Medicine,2016,29(05):5.
[9]卢如玲,古子娟,袁烁.补肾中药联合达英-35治疗多囊卵巢综合征疗效的Meta分析[J].西部中医药,2018,31(01):64.
　LU Ruling,GU Zijuan,YUAN Shuo.Meta Analysis of Clinical Effects of Kidney-tonifying Herbs Combined with Diane-35 in Treating Polycystic Ovarian Syndrome[J].Western Journal of Traditional Chinese Medicine,2018,31(05):64.
[10]雍志强,潘文△,张瑞瑞,等.补肾化瘀方对PCOS血清IKK表达的临床影响[J].西部中医药,2017,30(04):80.
　YONG Zhiqiang,PAN Wen,ZHANG Ruirui,et al.The Effects of BuShen HuaYu Prescription on Serum IKK Expression of PCOS Patients[J].Western Journal of Traditional Chinese Medicine,2017,30(05):80.

备注/Memo

备注/Memo:
袁仁智（1970—），男，博士学位，研究员。研究方向：中医临床文献及转化研究。国家自然科学基金（81660803）。
更新日期/Last Update: 2021-05-15